Daiichi Sankyo Leads Japan Pharma Stocks Higher on Cancer Drug

📆 25/09/2023 7:38:00
📰 YahooFinanceCA

⏱ Reading Time:
14 sec. here
2 min. at publisher
📊 Quality Score:
News: 9%
Publisher: 63%

España Noticias Noticias

España Últimas Noticias,España Titulares

(Bloomberg) -- Daiichi Sankyo Co. shares jumped by the most in a year after a drug it developed with AstraZeneca Plc showed favorable results in a trial for a common type of breast cancer.Most Read from BloombergChinese Gold Buying Is Driving a Paradigm Shift in BullionStocks Flash Recession Warning as Trouble Spreads to IndustrialsIndia-Canada Clash Should Be a Wakeup CallWells Fargo Preps for Wealth Battle After $1 Billion TurnaroundCorzine Plans to Shut Hedge Fund and Return Capital to Invest

Awkward Encounters: Pushing Limits of EmbarrassmentSome providers are dropping gender-affirming care for kids even in cases where it's legal

ST. LOUIS — As Republican-led states have rushed to ban gender-affirming for minors, some families with transgender children found a bit of solace: At least they lived in states that would allow those already receiving puberty blockers or hormone therapy to continue.

Escribir Comentario

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

España Últimas Noticias, España Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Daiichi Sankyo Leads Japan Pharma Stocks Higher on Cancer DrugDaiichi Sankyo Co. shares jumped by the most in a year after a drug it developed with AstraZeneca Plc showed favorable results in a trial for a common type of breast cancer.
Fuente: BNNBloomberg - 🏆 83. / 50 Leer más »